412 related articles for article (PubMed ID: 22122438)
21. Minichromosome Maintenance Proteins Cooperate with LANA during the G
Dabral P; Uppal T; Rossetto CC; Verma SC
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651368
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's Sarcoma Herpesvirus Genome Persistence.
Juillard F; Tan M; Li S; Kaye KM
Front Microbiol; 2016; 7():1149. PubMed ID: 27570517
[TBL] [Abstract][Full Text] [Related]
23. Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence.
Kelley-Clarke B; De Leon-Vazquez E; Slain K; Barbera AJ; Kaye KM
J Virol; 2009 May; 83(9):4326-37. PubMed ID: 19225000
[TBL] [Abstract][Full Text] [Related]
24. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication.
Fejér G; Medveczky MM; Horvath E; Lane B; Chang Y; Medveczky PG
J Gen Virol; 2003 Jun; 84(Pt 6):1451-1462. PubMed ID: 12771414
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.
Paudel N; Sadagopan S; Chakraborty S; Sarek G; Ojala PM; Chandran B
J Virol; 2012 Jun; 86(11):5974-91. PubMed ID: 22438557
[TBL] [Abstract][Full Text] [Related]
26. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
27. Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication.
Verma SC; Lu J; Cai Q; Kosiyatrakul S; McDowell ME; Schildkraut CL; Robertson ES
PLoS Pathog; 2011 Nov; 7(11):e1002365. PubMed ID: 22072974
[TBL] [Abstract][Full Text] [Related]
28. KSHV Genome Replication and Maintenance in Latency.
Ueda K
Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
[TBL] [Abstract][Full Text] [Related]
29. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.
Lu J; Verma SC; Cai Q; Robertson ES
J Virol; 2011 Jul; 85(13):6148-61. PubMed ID: 21507979
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation.
Si H; Verma SC; Lampson MA; Cai Q; Robertson ES
J Virol; 2008 Jul; 82(13):6734-46. PubMed ID: 18417561
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latency.
Ohsaki E; Suzuki T; Karayama M; Ueda K
Virus Res; 2009 Jan; 139(1):74-84. PubMed ID: 19027806
[TBL] [Abstract][Full Text] [Related]
32. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency.
Mariggiò G; Koch S; Zhang G; Weidner-Glunde M; Rückert J; Kati S; Santag S; Schulz TF
PLoS Pathog; 2017 Apr; 13(4):e1006335. PubMed ID: 28430817
[TBL] [Abstract][Full Text] [Related]
33. H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence.
Jha HC; Upadhyay SK; A J Prasad M; Lu J; Cai Q; Saha A; Robertson ES
J Virol; 2013 May; 87(9):5255-69. PubMed ID: 23449797
[TBL] [Abstract][Full Text] [Related]
34. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.
Ballestas ME; Chatis PA; Kaye KM
Science; 1999 Apr; 284(5414):641-4. PubMed ID: 10213686
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradation.
Nakajima K-i; Inagaki T; Espera JM; Izumiya Y
J Virol; 2024 Feb; 98(2):e0126823. PubMed ID: 38240588
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A.
Kim KY; Huerta SB; Izumiya C; Wang DH; Martinez A; Shevchenko B; Kung HJ; Campbell M; Izumiya Y
J Virol; 2013 Jun; 87(12):6782-93. PubMed ID: 23576503
[TBL] [Abstract][Full Text] [Related]
37. Assay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes.
Beauchemin C; Moerke NJ; Faloon P; Kaye KM
J Biomol Screen; 2014 Jul; 19(6):947-58. PubMed ID: 24518064
[TBL] [Abstract][Full Text] [Related]
38. The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner.
Verma SC; Choudhuri T; Robertson ES
J Virol; 2007 Apr; 81(7):3402-13. PubMed ID: 17151118
[TBL] [Abstract][Full Text] [Related]
39. KSHV LANA--the master regulator of KSHV latency.
Uppal T; Banerjee S; Sun Z; Verma SC; Robertson ES
Viruses; 2014 Dec; 6(12):4961-98. PubMed ID: 25514370
[TBL] [Abstract][Full Text] [Related]
40. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.
Cotter MA; Robertson ES
Virology; 1999 Nov; 264(2):254-64. PubMed ID: 10562490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
